Glioblastom – cauze, simptome, tratament - Cancer360
OC-0134: Irradiation-induced plasticity of the cancer stem cell population in prostate cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science
Glioblastom | Neurochirurgie Inselspital Bern
Prof. Dr. med. Ralf A. Kockro | Gliomas| Glioblastoma, Astrocytoma, Oligodendroglioma
Glioblastoma Multiforme – Symptoms, Diagnosis and Treatment Options
Frontiers | Current Approaches for Glioma Gene Therapy and Virotherapy
A review of glioblastoma tumors with primitive neuronal component and a case report of a patient with this uncommon tumor at a rare location - Shayganfar - 2020 - Clinical Case Reports - Wiley Online Library
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy | Nature Communications
Glioblastoma (Multiforme) Imaging: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging
Frontiers | Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy
Despre Glioblastom - Generalități - Glioblastom
Advanced magnetic resonance imaging in glioblastoma: a review - Shukla - Chinese Clinical Oncology
Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism - ScienceDirect
Frontiers | Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes
Prognosemarker für Glioblastom identifiziert | Gesundheitsstadt Berlin
Despre Glioblastom - Generalități - Glioblastom
Glioblastoma (Multiforme) Imaging: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging
Neue Gliom-Marker von Atlas Antibodies | BIOZOL
Frontiers | Immune Checkpoint Inhibitors in Human Glioma Microenvironment
Glioblastoma Multiforme | Concise Medical Knowledge
New marker for survival of glioblastoma patients discovered
Glioblastom | Neurochirurgie Inselspital Bern
Frontiers | Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse
